Yüklüyor......
The efficacy and safety of velagliflozin over 16 weeks as a treatment for insulin dysregulation in ponies
BACKGROUND: A previous six-week (wk) study demonstrated the potential of the sodium-glucose linked transport inhibitor velagliflozin as a novel treatment for equine insulin dysregulation. The present study examined the safety and efficacy of velagliflozin over 16 wk. of treatment, and over 4 wk. of...
Kaydedildi:
| Yayımlandı: | BMC Vet Res |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BioMed Central
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6390376/ https://ncbi.nlm.nih.gov/pubmed/30808423 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12917-019-1811-2 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|